ADVERTISEMENT

The Path To Commercialize CAR-T Cell Products

Different cancer treatments exist, but they each have variable efficacies and non-negligible side effects

Many innovative approaches are under development in research labs or are being tested in phase I/II trials. Among such treatments are genetically-engineered CAR T cells that bypass the natural function of patientsā€™ T cells to efficiently target and kill tumors. Two CAR T cell products were recently approved by the FDA, and their administration is limited to certified centers in the US.

ADVERTISEMENT

Dedicated manufacturing setups are necessary to produce such cells, rendering them more expensive than conventional treatments and less accessible to patients. CAR-T cells will possibly herald the first commercial success of industry-manufactured cellular therapies, an activity that has historically been developed and supported by academia in an organizational context different than the industrial pharma framework.

In this review, we discuss the hurdles on the path to commercialization of CAR T cells. The complexity of the supply chain, from primary cell collection to administration of a personalized medicinal product, is hardly amenable to the conventional central manufacturing processes used for conventional drug batch production. This warrants exploring whether alternative models of manufacturing (centralized versus point-of-care) is compatible with modern regulations, patient safety, and cost containment.

In part ā€” but not only ā€” because current organizations for manufacturing necessitate cross-border shipping of the starting material and of the medicinal product ready to be administered, a harmonization of regulations is needed to speed up access for patients in many countries. To paraphrase one of the first patients treated with CAR-T cells in the US, a treatment that is not accessible to many is not a cure at all.

CAR T cells also carry significant risks of toxicities. For broad applicability, engineering safety mechanisms into the gene constructs of CAR T cells is required.

ADVERTISEMENT

We also discuss avenues to increase the likelihood of commercial success of CAR T cells:

  • Point-of-care technologies can reduce the complexity of the supply chain by collecting cells from a patient, manufacturing CAR T cells, and infusing to the same patient at the same site;
  • Adopting an off-the-shelf approach for readily-available stocks/batches of CAR T cells accessible to large numbers of patients, as opposed to the current model of patient-specific CAR T cells; and
  • Building on the success of CAR T cells in leukemias and lymphomas to target other more prevalent tumors, such as solid tumors, is a most desirable goal, however, this implies a better knowledge of tumor antigens, trafficking of immune cells in the vicinity of tumor cells, and the immunosuppressive properties of the tumor microenvironment.
Figure: Major pharmaceutical industry players currently contributing to developments in the CAR-T cell field (Republished with permission from Elsevier)

These findings are described in the article entitled,Ā From clinical proof-of-concept to commercialization of CAR T cells, recently published in the journalĀ Drug Discovery Today.Ā This work was conducted by Boris Calmels, Bechara Mfarrej, and Christian Chabannon fromĀ Aix Marseille University and theĀ Institut Paoli-Calmettes.

Comments

READ THIS NEXT

Difference Between Plant And Animal Cells

The key difference between plant and animal cells lies in the structural differences. Plant cells are rectangular wheres animal cells […]

The Wisdom Of Crowds: When Collective Intelligence Surpasses Individual Intelligence

Consider a set of firms producing comparable goods. Each firm aims to strategically choose the selling price of their products […]

Associating Words With An Emotional Meaning

Reading our partnerā€™s name in a text message can immediately elicit emotions like happiness. In contrast, reading the name of […]

‘Firehawks’ Are Found To Be Deliberately Setting Forests On Fire

In recent years we have seen many wildfires ravaging vast areas in different countries. One of the countries that seem […]

Lines Of Longitude, With Maps

Lines of longitude are imaginary vertical lines that run north and south around the Earth and meeting at the North […]

What Is An Organelle?

An organelle is a general term for the small organs or subunits within a cell. Organelles are vital for the […]

Rhomboidal And Triangular Four- And Five-body Problems: Planar Central Configurations

Researchers established that many stars are part of multiple–star systems. Moreover, the ratio of multiple-star systems in our galaxy is […]

Science Trends is a popular source of science news and education around the world. We cover everything from solar power cell technology to climate change to cancer research. We help hundreds of thousands of people every month learn about the world we live in and the latest scientific breakthroughs. Want to know more?